BlackRock Health Sciences Opportunities Portfolio Service Shares SHISX

Morningstar Medalist Rating
  • NAV / 1-Day Return$70.44  /  +0.14%
  • Fund Size$6.6B
  • Adjusted Expense Ratio1.160%
  • Net Expense Ratio1.160%
  • Fee Level: DistributionAverage
  • Share Class TypeNo Load
  • Morningstar CategoryHealth
  • Equity Style Box (Funds)Large Value
  • Minimum Initial Investment$5,000
  • Investment StatusOpen
  • TTM Yield0.21%
  • Turnover Ratio49%

Morningstar’s Analysis SHISX

Will SHISX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

BlackRock Health Sciences Opps Svc holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHISX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings54.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

12.13760M
Healthcare

Johnson & Johnson

8.13510M
Healthcare

Merck & Co Inc

5.57349M
Healthcare

AbbVie Inc

5.27330M
Healthcare

Thermo Fisher Scientific Inc

4.91308M
Healthcare

Gilead Sciences Inc

4.24266M
Healthcare

Amgen Inc

3.97249M
Healthcare

UnitedHealth Group Inc

3.89244M
Healthcare

Danaher Corp

3.50219M
Healthcare

Vertex Pharmaceuticals Inc

3.26204M
Healthcare

Sponsor Center